If you are interested in participating in a Duke Vaccine and Trials Unit study, please contact us to receive notices about current and future research studies.
Email: dvtustudies@duke.edu | Telephone: 919-971-5649
Active Clinical Trials
Dr. Walter is leading a study designed to obtain blood from Duke employees who are recovering from SARS-CoV-2 infection for the purposes of neutralizing antibody assay validation. No NCT number.
Dr. Smith is leading a study to assess the safety and tolerability of a multivalent pneumococcal conjugate vaccine in adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07086677.
Dr. Walter is leading a study to learn about a Clostridioides difficile vaccine in people 65 years of age and older. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07282665.
Dr. Walter is leading a study to learn about a COVID-19 vaccine in healthy adults 50 through 64 years of age. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07300839.
Dr. Woods is leading a controlled human infection model study to determine the optimal dose of a pH1N1 influenza virus. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07110532.